Exane Derivatives’s iShares MSCI ACWI ETF ACWI Stock Holding History

Exane Derivatives’s Portfolio ACWI Stock Details ACWI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.98M	Buy	+35,530	New	+$3.23M	1.71%	10

Other funds holding ACWI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

MKP Capital Management New York $3.04B AUM 20.46% 1-Year Est. Return

FWM

FFT Wealth Management Philadelphia, Pennsylvania $638M AUM 21.7% 1-Year Est. Return

Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Exane Derivatives's ACWI Position: Q2 2022 in Review

Exane Derivatives opened a new position in iShares MSCI ACWI ETF (ACWI) in Q2 2022: 35,530 shares worth $2.98M. The stake represents 1.71% of the portfolio and ranks #10 among its holdings.

562 funds tracked by Wall St. Rank hold ACWI as of Q2 2022.

Exane Derivatives held 35,530 shares of iShares MSCI ACWI ETF worth $2.98M as of Q2 2022.
iShares MSCI ACWI ETF was a new Exane Derivatives position in Q2 2022.
iShares MSCI ACWI ETF made up 1.71% of Exane Derivatives's portfolio in Q2 2022, its #10 holding.
562 funds tracked by Wall St. Rank held iShares MSCI ACWI ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.